DrugDomain logoDrugDomain

Attributes

UniProt ID
Protein Name
Glycine receptor subunit alphaZ1
Ligand Name
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17 -oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacy clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
DrugBank ID
None
PDB Ligand Accession
ChEMBL ID
n/a
PubChem ID
n/a
InChIKey
AZSNMRSAGSSBNP-XPNPUAGNSA-N
SMILES
CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C
Drug Action
No data available
Affinity Metrics
No affinity data available

3D Structure

Interactive Mol* view for the current protein-molecule pair.

Structure: 3JAF
Hover over the Mol* viewer to rotate or zoom with the mouse. Move the cursor out of the viewer to go back to normal page scrolling and one-click navigation.
Hover inside the viewer to rotate or zoom. Move out to scroll the page or click links normally.
Color Legend
Unassigned regionsLigand / hetero atomse3jafA1e3jafA2e3jafB1e3jafB2e3jafC1e3jafC2e3jafD1e3jafD2e3jafE1e3jafE2
ECOD domains from experimental PDB structures interacting with ligand IVM
UniProtDrugBankPDB LigandPDB IDECOD DomainRange Definition
O93430n/aIVM3jafe3jafA1A:25-237
O93430n/aIVM3jafe3jafA2A:236-366
O93430n/aIVM3jafe3jafB1B:25-237
O93430n/aIVM3jafe3jafB2B:236-366
O93430n/aIVM3jafe3jafC1C:25-237
O93430n/aIVM3jafe3jafC2C:236-366
O93430n/aIVM3jafe3jafD1D:236-366
O93430n/aIVM3jafe3jafD2D:25-237
O93430n/aIVM3jafe3jafE1E:236-366
O93430n/aIVM3jafe3jafE2E:25-237
O93430n/aIVM6vm0e6vm0A1A:31-245
O93430n/aIVM6vm0e6vm0A2A:244-336,A:401-444
O93430n/aIVM6vm0e6vm0B1B:31-245
O93430n/aIVM6vm0e6vm0B2B:244-336,B:401-444
O93430n/aIVM6vm0e6vm0C1C:244-336,C:401-444
O93430n/aIVM6vm0e6vm0C2C:31-245
O93430n/aIVM6vm0e6vm0D1D:244-336,D:401-444
O93430n/aIVM6vm0e6vm0D2D:31-245
O93430n/aIVM6vm0e6vm0E1E:31-245
O93430n/aIVM6vm0e6vm0E2E:244-336,E:401-444
O93430n/aIVM6vm2e6vm2A1A:244-336,A:401-444
O93430n/aIVM6vm2e6vm2A2A:31-245
O93430n/aIVM6vm2e6vm2B1B:31-245
O93430n/aIVM6vm2e6vm2B2B:244-336,B:401-444
O93430n/aIVM6vm2e6vm2C1C:31-245
O93430n/aIVM6vm2e6vm2C2C:244-336,C:401-444
O93430n/aIVM6vm2e6vm2D1D:31-245
O93430n/aIVM6vm2e6vm2D2D:244-336,D:401-444
O93430n/aIVM6vm2e6vm2E1E:31-245
O93430n/aIVM6vm2e6vm2E2E:244-336,E:401-444
O93430n/aIVM6vm3e6vm3A1A:244-336,A:401-444
O93430n/aIVM6vm3e6vm3A2A:32-245
O93430n/aIVM6vm3e6vm3B1B:32-245
O93430n/aIVM6vm3e6vm3B2B:244-336,B:401-444
O93430n/aIVM6vm3e6vm3C1C:32-245
O93430n/aIVM6vm3e6vm3C2C:244-336,C:401-444
O93430n/aIVM6vm3e6vm3D1D:244-336,D:401-444
O93430n/aIVM6vm3e6vm3D2D:32-245
O93430n/aIVM6vm3e6vm3E1E:244-336,E:401-444
O93430n/aIVM6vm3e6vm3E2E:32-245
O93430n/aIVM8fe1e8fe1A1A:244-336,A:401-444
O93430n/aIVM8fe1e8fe1A2A:33-245
O93430n/aIVM8fe1e8fe1B1B:31-245
O93430n/aIVM8fe1e8fe1B2B:244-336,B:401-444
O93430n/aIVM8fe1e8fe1C1C:31-245
O93430n/aIVM8fe1e8fe1C2C:244-336,C:401-444
O93430n/aIVM8fe1e8fe1D2D:244-336,D:401-444